Status:
COMPLETED
A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
Lead Sponsor:
Kwang Dong Pharmaceutical co., ltd.
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
19-65 years
Phase:
PHASE4
Brief Summary
A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in adults with Vitamin D Deficiency
Eligibility Criteria
Inclusion
- Subjects with vitamin D deficiency
Exclusion
- Subjects who experienced a hypersensitivity to the cholecalciferol
- Subjects with Hypercalcemia
- Subjects with Hypercalciuria
- Subjects with renal impairment
- Subjects with calcium stone
- Subjects diagnosed with sarcoidosis or pseudo-hypoparathyroidism
- Subjects who are to take vitamin D supplements during the study period
Key Trial Info
Start Date :
October 23 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 27 2016
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03233295
Start Date
October 23 2014
End Date
August 27 2016
Last Update
July 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.